SARS-CoV-2 virus antibodies IgM semiquantitative

Coronavirus COVID-19 antibody test IgM

What is the serologic antibody test anti-SARS-COV-2?

• The test detects IgM antibodies in venous blood serum, appearing as a result of contact with the virus. The determination of antibodies is performed using a semi-quantitative method.
• The test is performed using a semi-quantitative method
• The tests used in our laboratories are certified approving their use for diagnostic purposes in humans.

• The test requires no preparation. There is no need to be fasting.

• The test does not require preparation

• After purchasing the test, all you need to do is report to the collection center at the facility where the test was purchased.

• After purchasing the test, simply visit the collection center at the facility where the test was purchased

Coronavirus COVID-19 test (antibody test IgM) when to perform?

• in epidemiological studies to determine the spread of the infection;
• in order to detect individuals who have passed the infection asymptomatically or sparsely symptomatic;
• testing of recovered patients, in order to obtain plasma for therapeutic purposes
• in retrospective epidemiological studies to detect individuals who have been in contact with the virus and may have developed immune mechanisms immunity.

Determination of anti-SARS-COV-2 antibodies by semi-quantitative method

Aims to assess changes in antibody concentration over time, which can be useful in the process of epidemiological management.

Important information: Patients showing symptoms of COVID-19 infection (high fever, cough, shortness of breath, muscle pain, weakness) should immediately contact the nearest sanitary and epidemiological station by phone sanitary-epidemiological station or go to an infectious disease hospital.

FREQUENTLY ASKED QUESTIONS:

What is the difference between IgG and IgM antibodies?

The concentration of serum IgM antibodies increases in the first days of infection and then gradually decreases. Therefore, their presence indicates the early stage of infection caused by SARS-CoV-2. In turn, IgG antibodies are referred to as so-called late-stage infection antibodies. The presence of IgG antibodies alone indicates that the infection occurred earlier than a few weeks ago.

When is it better to determine IgG and when IgM?

Antibodies begin to be produced approximately 1-2 weeks after the onset of the symptoms. Antibody tests for IgM and/or IgG are usually performed about 2-3 weeks after the COVID-19 symptoms appear – at this stage, their concentration is the highest. Serological tests that are performed too early may give a false negative result due to the so-called serological window, i.e. the period of time when antibodies are not yet detectable.

When is it worth doing the antibody test?

Antibody testing is especially recommended to identify individuals who have had COVID-19 in either asymptomatic or oligosymptomatic form, or if the patient had symptoms of a respiratory infection but did not perform the test to confirm SARS-CoV-2 infection. The antibody testing allows the identification of the so-called convalescents who can donate plasma to help other sick people.

When to propose the IgG + IgM combination test? Is it more reliable/accurate/ better than single IgG and IgM tests?

The detection of IgM and IgG antibodies suggests that the infection took place in the last few weeks. The sensitivity and specificity of this test (i.e. its reliability) varies depending on the timing. It was determined that the reliability of the combined IgM and IgG tests was the highest when it was performed on days 22-35 from the onset of the symptoms, as well as on days 15-21. At all analysed time points, its sensitivity was higher than for single antibody tests (Cochrane, 2020).

Are the tests results recognised by the National Health Fund if someone wants to donate plasma?

The convalescents are required to confirm, or at least strongly prove, the actual history of SARS-CoV-2 infection. For instance, positive result of the quantitative test of anti-SARS-CoV-2 IgG class antibodies is considered to be sufficient evidence of a SARS-CoV-2 infection. Semi-quantitative tests are available at Medicover.

What does the semi-quantitative method mean?

The semi-quantitative test differs from the qualitative test in that it both detects IgG and IgM antibodies and also allows to determine the level of these antibodies. However, it is not a method as accurate as quantitative test that assesses the titer (amount) of antibodies in the plasma. For more detailed information, please visit the Synevo laboratory website: https://www.synevo.pl/test-na-przeciwciala-koronawirusa-polilosciowo/.

Are these tests recognised when travelling and crossing the border?

Due to the current epidemic situation, the Ministry of Foreign Affairs recommends to avoid traveling abroad especially when it is not absolutely necessary. The conditions to be met by a person crossing the border of a given country differ between countries – before planning a trip, please read the information on https://www.gov.pl/web/dyplomacja/informacje-dla-podrozujacych. If a negative SARS-CoV-2 infection test result is required before you are allowed to enter a country, it is usually a PCR test result (nasopharyngeal swab) – not an antibody test.